The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study von de Bruijne, E L E, Gils, A, Guimarães, A H C, Dippel, D W J, Deckers, J W, van den Meiracker, A H, Poldermans, D, Rijken, D C, Declerck, P J, de Maat, M P M, Leebeek, F W G

Volltext

New insights into the molecular mechanisms of the fibrinolytic system von RIJKEN, D. C., LIJNEN, H. R.

Volltext

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH von Pieters, M., Philippou, H., Undas, A., de Lange, Z., Rijken, D.C., Mutch, N.J.

Volltext

Development of a new test for the global fibrinolytic capacity in whole blood von RIJKEN, D. C., HOEGEE‐DE NOBEL, E., JIE, A. F. H., ATSMA, D. E., SCHALIJ, M. J., NIEUWENHUIZEN, W.

Volltext

A new functional assay of thrombin activatable fibrinolysis inhibitor von GUIMARÃES, A. H. C., BERTINA, R. M., RIJKEN, D. C.

Volltext

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII von Rijken, D. C., Abdul, S., Malfliet, J. J. M. C., Leebeek, F. W. G., Uitte de Willige, S.

Volltext

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests von RIJKEN, D. C., KOCK, E. L., GUIMARÃES, A. H. C., TALENS, S., MURAD, S. DARWISH, JANSSEN, H. L. A., LEEBEEK, F. W. G.

Volltext

Increased N‐terminal cleavage of alpha‐2‐antiplasmin in patients with liver cirrhosis von Uitte de Willige, S., Malfliet, J. J. M. C., Janssen, H. L. A., Leebeek, F. W. G., Rijken, D. C.

Volltext

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: reply von Rijken, D. C., Abdul, S., Malfliet, J. J. M. C., Leebeek, F. W. G., Uitte De Willige, S.

Volltext

Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture von Rijken, D C, Collen, D

Volltext

The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor von BOVENSCHEN, N., RIJKEN, D. C., HAVEKES, L. M., VLIJMEN, B. J. M., MERTENS, K.

Volltext

Identification and characterization of α1‐antitrypsin in fibrin clots von Talens, S., Malfliet, J. J. M. C., Hal, P. Th. W., Leebeek, F. W. G., Rijken, D. C.

Volltext

High functional levels of thrombin‐activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke von LEEBEEK, F. W. G., GOOR, M. P. J., GUIMARAES, A. H. C., BROUWERS, G.‐J., MAAT, M. P. M., DIPPEL, D. W. J., RIJKEN, D. C.

Volltext

Binding of tissue-type plasminogen activator by the mannose receptor von Otter, M, Barrett-Bergshoeff, M M, Rijken, D C

Volltext

Oxidized high‐density lipoprotein reduces blood clot firmness von Talens, S., Malfliet, J. J. M. C., Leebeek, F. W. G., Rijken, D. C.

Volltext

Binding of carboxypeptidase N to fibrinogen and fibrin von Talens, S., Lebbink, J.H.G., Malfliet, J.J.M.C., Demmers, J.A.A., Uitte de Willige, S., Leebeek, F.W.G., Rijken, D.C.

Volltext

Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children von EMONTS, M., DE BRUIJNE, E. L. E., GUIMARÃES, A. H. C., DECLERCK, P. J., LEEBEEK, F. W. G., DE MAAT, M. P. M., RIJKEN, D. C., HAZELZET, J. A., GILS, A.

Volltext

Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot von Rijken, D.C., Dirkx, S.P.G., Luider, T.M., Leebeek, F.W.G.

Volltext

Basic Principles in Thrombolysis: Regulatory Role of Plasminogen von Rijken, D.C., Sakharov, D.V.

Volltext

Relationship between tissue plasminogen activator and the activators in blood and vascular wall von Rijken, D.C., Wijngaards, G., Welbergen, J.

Volltext